Bausch + Lomb Corporation
BLCONYSEHealthcare● Active
$15.52
+$0.06(+0.39%)
Market Cap$5.5B
P/E Ratio—
52W High$18.915
52W Low$11.44
Bausch + Lomb Corporation (BLCO) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BLCO · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 29, 2026EPS Actual
$0.08
Est. $0.06 · +33.3%
Revenue
$1.24B
Est. $1.22B · +2.3%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 29, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
BLCO reports quarterly as a NYSE-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.84B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.84B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 29, 2026 | $0.16 | — | — | — | $1.37B | — |
| ▲ Q2 FY2026 | Apr 29, 2026 | $0.06 | $0.08 | +33.3% | $1.24B | $1.22B | +2.3% |
| ▼ Q1 FY2026 | Feb 18, 2026 | $0.35 | $0.32 | -8.6% | $1.41B | $1.39B | +1.4% |
| ▲ Q4 FY2025 | Oct 29, 2025 | $0.16 | $0.18 | +12.5% | $1.28B | $1.38B | -7.4% |
| ▲ Q3 FY2025 | Jul 30, 2025 | $0.06 | $0.07 | +16.7% | $1.28B | $1.27B | +0.3% |
| ▼ Q2 FY2025 | Apr 30, 2025 | $0.03 | -$0.07 | -333.3% | $1.13B | $1.25B | -9.6% |
| ▲ Q1 FY2025 | Feb 19, 2025 | $0.24 | $0.25 | +4.2% | $1.28B | $1.15B | +11.2% |
| ▲ Q4 FY2024 | Oct 30, 2024 | $0.16 | $0.17 | +6.3% | $1.20B | $1.25B | -4.7% |
Q3 FY2026
Jul 29, 2026
EPS Actual
—
EPS Est.
$0.16
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 29, 2026Beat
EPS Actual
$0.08
EPS Est.
$0.06
EPS Surpr.
+33.3%
Revenue
$1.24B
Q1 FY2026
Feb 18, 2026Miss
EPS Actual
$0.32
EPS Est.
$0.35
EPS Surpr.
-8.6%
Revenue
$1.41B
Q4 FY2025
Oct 29, 2025Beat
EPS Actual
$0.18
EPS Est.
$0.16
EPS Surpr.
+12.5%
Revenue
$1.28B
Q3 FY2025
Jul 30, 2025Beat
EPS Actual
$0.07
EPS Est.
$0.06
EPS Surpr.
+16.7%
Revenue
$1.28B
Q2 FY2025
Apr 30, 2025Miss
EPS Actual
-$0.07
EPS Est.
$0.03
EPS Surpr.
-333.3%
Revenue
$1.13B
Q1 FY2025
Feb 19, 2025Beat
EPS Actual
$0.25
EPS Est.
$0.24
EPS Surpr.
+4.2%
Revenue
$1.28B
Q4 FY2024
Oct 30, 2024Beat
EPS Actual
$0.17
EPS Est.
$0.16
EPS Surpr.
+6.3%
Revenue
$1.20B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.37 | $0.38 | $0.38 | 6 |
| Q3 FY2027 | $0.26 | $0.26 | $0.27 | 3 |
| Q2 FY2027 | $0.26 | $0.26 | $0.26 | 5 |
| Q1 FY2027 | $0.16 | $0.16 | $0.16 | 3 |
| Q4 FY2026 | $0.35 | $0.36 | $0.36 | 6 |
| Q3 FY2026 | $0.22 | $0.22 | $0.24 | 8 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $1.6B | $1.6B | $1.6B | 7 |
| Q3 FY2027 | $1.4B | $1.4B | $1.5B | 4 |
| Q2 FY2027 | $1.4B | $1.4B | $1.5B | 6 |
| Q1 FY2027 | $1.3B | $1.3B | $1.3B | 4 |
| Q4 FY2026 | $1.5B | $1.5B | $1.5B | 7 |
| Q3 FY2026 | $1.4B | $1.4B | $1.4B | 8 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 29, 2026 | +33.3% | $15.72 | $15.34 | -2.42% |
| ▼ Q1 FY2026 | Feb 18, 2026 | -8.6% | $17.73 | $17.67 | -0.34% |
| ▲ Q4 FY2025 | Oct 29, 2025 | +12.5% | $15.20 | $15.47 | +1.78% |
| ▲ Q3 FY2025 | Jul 30, 2025 | +16.7% | $14.65 | $13.71 | -6.42% |
| ▼ Q2 FY2025 | Apr 30, 2025 | -333.3% | $13.72 | $11.56 | -15.74% |
| ▲ Q1 FY2025 | Feb 19, 2025 | +4.2% | $16.35 | $16.30 | -0.31% |
| ▲ Q4 FY2024 | Oct 30, 2024 | +6.3% | $20.76 | $20.44 | -1.54% |
| ▲ Q3 FY2024 | Jul 31, 2024 | +0.0% | $16.87 | $17.22 | +2.07% |
Q2 FY2026-2.42%
Report Date
Apr 29, 2026
EPS Beat/Miss
+33.3%
Price Before
$15.72
Price After
$15.34
Q1 FY2026-0.34%
Report Date
Feb 18, 2026
EPS Beat/Miss
-8.6%
Price Before
$17.73
Price After
$17.67
Q4 FY2025+1.78%
Report Date
Oct 29, 2025
EPS Beat/Miss
+12.5%
Price Before
$15.20
Price After
$15.47
Q3 FY2025-6.42%
Report Date
Jul 30, 2025
EPS Beat/Miss
+16.7%
Price Before
$14.65
Price After
$13.71
Q2 FY2025-15.74%
Report Date
Apr 30, 2025
EPS Beat/Miss
-333.3%
Price Before
$13.72
Price After
$11.56
Q1 FY2025-0.31%
Report Date
Feb 19, 2025
EPS Beat/Miss
+4.2%
Price Before
$16.35
Price After
$16.30
Q4 FY2024-1.54%
Report Date
Oct 30, 2024
EPS Beat/Miss
+6.3%
Price Before
$20.76
Price After
$20.44
Q3 FY2024+2.07%
Report Date
Jul 31, 2024
EPS Beat/Miss
+0.0%
Price Before
$16.87
Price After
$17.22
Avg Beat Reaction-1.14%
Avg Miss Reaction-8.04%
Beat Rate6 / 8 quarters
Largest Move-15.74% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BLCO ends December
Bausch + Lomb Corporation (BLCO) most recently reported earnings on April 29, 2026 for Q2 FY2026, posting EPS of $0.08 — beating the analyst consensus of $0.06 by +33.3%. The next BLCO earnings date is expected around September 1, 2026.
Each quarter, investors track BLCO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BLCO revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BLCO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BLCO earnings · 5 questionsBausch + Lomb Corporation's next earnings report is expected around September 1, 2026. BLCO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BLCO historically reports after market close (AMC).
BLCO earnings datewhen is BLCO earningsBLCO next earnings datewhen does BLCO report earningsBLCO earnings calendar
▸ Source: FMP · Bausch + Lomb Corporation SEC filings · US GAAP · Bausch + Lomb Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026